Binding of monoclonal anti-interleukin 2 antibody to nucleoli in acute leukemia blast cells

Leuk Res. 1992 Jun-Jul;16(6-7):589-95. doi: 10.1016/0145-2126(92)90007-t.

Abstract

Neutralizing anti-IL-2, anti-IL-3, and anti-IL-6 monoclonal antibodies (MAbs) were used for the immunoenzymatic detection of the respective cytokines in blast cells of 38 patients with acute myeloid (AML) and lymphoid (ALL) leukemias by the APAAP-technique. In 20/24 AML-cases (83%) blast cells showed intranuclear staining with MAb anti-IL-2 (DMS-1). In 17 cases reaction was restricted to the nucleoli, in 4 cases additional cytoplasmic staining was observed. Only 2/13 (15%) of the ALL cases showed anti-IL-2 staining. In contrast to IL-2, neither IL-3, IL-6 nor IL-2R alpha-chains were detected in any of the acute leukemias tested. The anti-IL-2 staining of nucleoli in AML cells is distinct from the cytoplasmic staining which is observed in PHA-activated normal lymphocytes and in a minority of AML cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / metabolism
  • Binding Sites, Antibody
  • Cell Nucleolus / immunology
  • Cytoplasm / immunology
  • Humans
  • Immunoenzyme Techniques
  • Interleukin-2 / immunology*
  • Interleukin-3 / immunology
  • Interleukin-6 / immunology
  • Leukemia, Myelomonocytic, Acute / immunology*
  • Lymphocyte Activation
  • Lymphocytes / immunology
  • Monocytes / immunology
  • Neoplastic Stem Cells / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology*

Substances

  • Antibodies, Monoclonal
  • Interleukin-2
  • Interleukin-3
  • Interleukin-6